Leaflet PRONORAN 50mg prolonged-release sugar-coated tablets
Indicated for: Parkinson's disease
Route of administration: oral
Substance: piribedil (antiparkinsonian agent)
ATC: N04BC08 (Nervous system | Dopaminergic agents | Dopamine agonists)
This medicine may affect your ability to drive or use machines.
This medicine may cause dizziness or vertigo.
May lower blood pressure and increase the risk of falls.
This medicine may cause drowsiness or reduced alertness.
Piribedil is a medication used in the treatment of Parkinson's disease and other neurological conditions associated with dopamine deficiency.
It is a dopamine receptor agonist that helps improve motor control and reduce symptoms such as tremors, rigidity, and bradykinesia.
Piribedil is often used as monotherapy in the early stages of Parkinson's disease or in combination with levodopa in advanced stages.
It may also be used to treat peripheral circulatory disorders and certain eye conditions, such as retinopathy.
Common side effects include nausea, dizziness, drowsiness, and orthostatic hypotension.
In rare cases, hallucinations or compulsive behaviors, such as excessive gambling or compulsive eating, may occur.
It is important for patients to strictly follow their doctor's recommendations and report any unusual side effects.
Piribedil should be used with caution in patients with a history of psychotic disorders or cardiovascular diseases.
General data about PRONORAN 50mg
- Substance: piribedil
- Date of latest medicines list: 01-06-2026
- Product code: W10479001
- Concentration: 50mg
- Pharmaceutical form: prolonged-release sugar-coated tablets
- Quantity: 30
- Product type: Original
- Price: 34.28 RON
- Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Compensation lists for PRONORAN 50mg Servier
B - Sublist B with 50% discount from the reference price
Price
Copayment
Patient
34.28 RON
13.47 RON
20.81 RON